Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Gross Profit Over TimeStable
Percentile Rank57
3Y CAGR-1.2%
5Y CAGR-1.5%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-1.2%/yr
vs +38.7%/yr prior
5Y CAGR
-1.5%/yr
Consistent
Acceleration
-39.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$9.65M+7.0%
2024$9.02M+9.0%
2023$8.27M-17.4%
2022$10.02M-20.5%
2021$12.60M+21.0%
2020$10.41M+20.3%
2019$8.66M+219.4%
2018$2.71M-